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Abstract
Background: Although brucellosis (Brucella spp.) and Q Fever (Coxiella burnetii) are zoonoses of global importance, very
little high quality data are available from West Africa.
Methods/Principal Findings: A serosurvey was conducted in Togo’s main livestock-raising zone in 2011 in 25 randomly
selected villages, including 683 people, 596 cattle, 465 sheep and 221 goats. Additionally, 464 transhumant cattle from
Burkina Faso were sampled in 2012. The serological analyses performed were the Rose Bengal Test and ELISA for brucellosis
and ELISA and the immunofluorescence assay (IFA) for Q Fever Brucellosis did not appear to pose a major human health
problem in the study zone, with only 7 seropositive participants. B. abortus was isolated from 3 bovine hygroma samples,
and is likely to be the predominant circulating strain. This may explain the observed seropositivity amongst village cattle
(9.2%, 95%CI:4.3–18.6%) and transhumant cattle (7.3%, 95%CI:3.5–14.7%), with an absence of seropositive small ruminants.
Exposure of livestock and people to C. burnetii was common, potentially influenced by cultural factors. People of Fulani
ethnicity had greater livestock contact and a significantly higher seroprevalence than other ethnic groups (Fulani: 45.5%,
95%CI:37.7–53.6%; non-Fulani: 27.1%, 95%CI:20.6–34.7%). Appropriate diagnostic test cut-off values in endemic settings
requires further investigation. Both brucellosis and Q Fever appeared to impact on livestock production. Seropositive cows
were more likely to have aborted a foetus during the previous year than seronegative cows, when adjusted for age. This
odds was 3.8 times higher (95%CI: 1.2–12.1) for brucellosis and 6.7 times higher (95%CI: 1.3–34.8) for Q Fever.
Conclusions: This is the first epidemiological study of zoonoses in Togo in linked human and animal populations, providing
much needed data for West Africa. Exposure to Brucella and C. burnetii is common but further research is needed into the
clinical and economic impact.
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Introduction
Brucellosis is one of the most common zoonotic diseases globally
[1]. Brucella spp are transmitted to people through the consump-
tion of unpasteurised dairy products or direct contact with infected
animals, particularly abortion materials [2,3]. This bacterial
disease causes not only a severely debilitating and disabling illness
[4], but also has major economic ramifications due to time lost by
patients from normal daily activities [2] and losses in animal
production [5]. High quality incidence data for human brucellosis
are predominantly available from the Middle East and North
Africa region [6] with no high quality data published from West
Africa. Exposure to Brucella has been demonstrated in cattle
populations in West Africa [7–10], with B. abortus isolated from
bovine hygromas in Mali [10] and the Gambia [7].
In recent years, Coxiella burnetii has become a bacterial zoonosis
of increasing interest, due to an unprecedented, large-scale
outbreak of Q Fever in the Netherlands from 2007–2010 with
approximately 4,000 notified human cases [11]. The most
common route of infection for people is the inhalation of dust
contaminated by infected animal fluids, followed by ingestion,
particularly of unpasteurised dairy products [12,13]. The global
importance of Q Fever is unknown. In West Africa, there is
evidence of exposure to the organism amongst fever patients in
Mali [14], but more representative and comprehensive seroprev-
alence and clinical data are needed.
A One Health approach to disease prevention and control not
only fosters collaboration between human and animal health
sectors, but also brings additional benefits to each [15]. The
economic benefits include those generated through the sharing of
resources such as vehicles or field equipment [16,17], or through a
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reduced burden on the health care system by controlling diseases
in the animal reservoir [5,18]. The simultaneous assessment of
exposure in people and animals provides a more complete picture
of the disease epidemiology, deepening our understanding of
disease risk and providing an important knowledge base for policy
development. In resource-poor settings, an integrated human-
animal health system is particularly needed in order to increase the
cost effectiveness of disease prevention and control interventions,
improve the efficiency of disease surveillance and response, and
strengthen the health system as a whole [19].
In Togo, animal brucellosis was first documented in the 1960s
[20]. Although bovine brucellosis seroprevalence studies [21] and
Brucella sp. identification [22] were conducted in the 1980s and
early 1990s, simultaneous assessment of exposure patterns in
people and livestock was lacking. The Savannah Region is Togo’s
principal livestock-raising zone. Being the northernmost of five
administrative regions, it is bordered by Ghana to the west,
Burkina Faso to the north, and Benin to the east. Cross-border
livestock movements are an inherent component of livestock
management practices, via largely unregulated trade routes or
semi-nomadic movements known as transhumance [23]. Official
policy for transhumance in West Africa was agreed upon in 1998
by member countries of the Economic Community of West
African States (ECOWAS). Togo permits the entry of foreign
herds in search of pasture and watering points from January to
May of each year. The Savannah Region of Togo is, therefore, a
diverse epidemiological setting, with its livestock disease status
likely to be linked to that of neighbouring countries.
Methods
Ethics Statement
This study was approved by the Ethics Committee for Health
Research (Comite´ de Bioe´thique pour la Recherche en Sante´) of
the Ministry of Health of Togo (ref. 0131/2011/MS/CAB/DGS/
DPLET/CBRS) and the Livestock Division (Direction de
l’Elevage) of the Ministry of Agriculture, Livestock Production
and Fisheries of Togo. In Switzerland, approval was given by the
Ethics Commission of the Cantons of Basel-Stadt and Basel-Land
(Ethikkommission beider Basel) (ref. 146/10) and the Research
Commission of the Swiss Tropical and Public Health Institute of
Basel, Switzerland. Informed written consent was obtained from
all literate participants or, in the case of minors, from their parents
or guardian. For illiterate participants, informed consent was
recorded with a fingerprint, which was witnessed and documented
in writing by a literate acquaintance of the participant. Obtaining
consent in this way was approved by the aforementioned ethics
commissions. The collection of blood samples from animals was
always supervised by a veterinarian. Animals were handled in
manner aiming to minimise stress and suffering, and were only
restrained for the shortest period of time necessary.
Village Serosurvey
Using a detailed regional map and MapInfo ProfessionalH 7.0
SCP, 25 geographical coordinates were randomly selected from
the Savannah Region, excluding national parks where settlements
were prohibited. The 25 villages closest to each coordinate were
visited in May – June 2011 and enrolled in the study after approval
from the village chief (see Figure 1). A day was allocated for the
study team to return to conduct the survey in each village. The
study team included nurses from local health centres, as well as
veterinary technicians and veterinarians. Cluster sample sizes were
calculated using the formula of Bennett [24] with 95% confidence
intervals according to Newcome [25].
Household and participant selection. Due to the absence
of a household list, a central point in the village was identified and
a direction selected by spinning a pen. The number of houses from
the centre to the edge of the village was counted in this direction,
and a number randomly selected between 1 and the total number
of houses. The household corresponding to this number was
identified by counting the doors in this direction, moving away
from the central point. The study was explained in the local
language and one adult and one child aged between 5–14 years of
age were enrolled by randomly selecting from those household
members willing to participate. The household with its door closest
to the first selected household was also visited and a further two
participants enrolled. The team then returned to the centre of the
village to choose a second direction. An intraclass correlation
coefficient of 0.1 and an expected brucellosis seroprevalence of 3%
[26] were assumed. A sample size of 15 people from 25 villages
would achieve a precision corresponding to a 95% confidence
interval not wider than 6 percentage points. Consequently, the
sampling procedure above was repeated until a total of 7–8
households were enrolled in each village, i.e. 14–16 people.
The majority of cattle herds in northern Togo are managed by
people of Fulani ethnicity, pastoralist communities who represent
the most dispersed ethnic group in West Africa [27,28]. Fulani
communities represent only a very small proportion of the overall
population of each village, and their households are often clustered
at the edge of village. As the household selection procedure
described above for the general population would not have
provided an adequate sample size from the Fulani communities of
each village, targeted sampling was conducted. Approval was first
sought from the Fulani chief and the community members were
then gathered together to explain the aims and methods of the
study. Participants were selected from those willing to participant
by random number allocation. The planned sample size for the
Fulani was 14–16 people, thus totalling 28–30 people per village
(half of which were Fulani).
Blood was collected from people by a trained nurse, in parallel
with data relating to the presence of specific symptoms during the
previous month (fever, headache, night-time sweats, sleeping
difficulties, or muscle, joint or nerve pain). Basic data relating to
demography (age, sex, ethnicity) and risk factor exposure were
collected through structured interviews with participants or their
parent/guardian. The risk factors assessed were the consumption
of dairy products (from any species) that had not been subjected to
heat treatment (boiling), and contact with either cattle or small
ruminants, where contact was defined as living in a household that
owned or looked after cattle or small ruminants.
Animal sampling. In each village, households owning cattle
and/or small ruminants (sheep, goats) were identified through
discussion with the village chief, the Fulani chief, and the local
veterinary technician. In each village, these households were
visited by the study team and invited to participate. Owners were
requested in advance to keep their animals nearby their homes on
the pre-selected sampling day. As a full census of the village’s
livestock population was not available, sampling was distributed
across all identified herds by dividing the total desired number per
village by the number of herds/flocks to obtain the number of
animals to be randomly sampled per herd/flock. Animals under 3
months of age were excluded. An intraclass correlation coefficient
of 0.1 [29] and an expected brucellosis seroprevalence of 5% in
cattle and 1% in small ruminants [26] were assumed. A sample
size of 20 cattle and 25 small ruminants from 25 villages would
achieve a precision corresponding to a 95% confidence interval
not wider than 7 percentage points for cattle and 4 percentage
points for small ruminants.
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Blood collection was performed by a veterinarian and veterinary
technician. Individual and herd data (age, sex, herd size, abortions
during previous year, and abortions during reproductive life for
transhumant cattle only) were obtained through structured
interviews with herd owners or herdsmen.
Transhumant Serosurvey
In February – March 2012, information about the location of
transhumant cattle herds was obtained from key informants,
including local livestock owners and herders, Fulani communities,
and animal health personnel. Given the available resources and
time period, a sample size of 15 herds was deemed to be realistic,
with 25 animals per herd based on an expected brucellosis
seroprevalence of 5% [24,25]. Blood collection from cattle as well
as structured interviews with herdsmen were conducted as per the
village survey. Blood samples were not collected from the
herdsmen.
Serological Analyses
After collection, all blood samples were immediately chilled on
ice and centrifuged the same day. Serum was then collected and
frozen at 220uC until analysis. Sera from the village survey were
transported frozen according to international biosafety standards
to the Swiss Tropical and Public Health Institute in Basel,
Switzerland for serological analysis. Sera from the transhumant
survey were analysed at the Central Veterinary Laboratory of the
Ministry of Agriculture, Livestock and Fisheries in Lome´, Togo,
and training was provided to the laboratory technicians. A sub-
sample of the sera tested in Switzerland was re-tested in Togo for
comparison, to ensure an agreement of results by the two
laboratories.
Brucellosis. All human samples were tested by the Rose
Bengal Test (RBT) (Brucella Rose Bengale, Bio-Rad Laboratories,
CA, USA), using a serum:reagent ratio of 1:1 for 8 minutes.
Positive sera were sequentially diluted with saline to obtain
dilutions from 1/2 to 1/16, then retested as per the protocol of
Diaz et al [30]. Additionally, all sera were tested by indirect IgG
ELISA. Samples positive by IgG ELISA or RBT were also tested
by IgM ELISA (Serion ELISA classic Brucella IgM/IgG, Institut
Virion\Serion GmbH, Wu¨rzburg, Germany), in order to identify
recent infections. Samples were classified as positive or negative
according to the manufacturer’s recommended cut-off ranges and
doubtful samples were re-tested.
All animal samples were tested by the RBT, using a
serum:reagent ratio of 1:1 for cattle and 3:1 for small ruminants
for 4 minutes, as per recommendations of the World Organisation
for Animal Health (OIE) [31]. Additionally, all samples were
tested by indirect ELISA (CHEKIT Brucellose Serum ELISA Test
Kit, IDEXX Laboratories, ME, USA) and classified as positive or
negative according to the manufacturer’s recommended cut-off
ranges. Samples positive by RBT but negative by ELISA were
tested by the Complement Fixation Test according to OIE
standards at the Institute for Veterinary Bacteriology, University
of Bern.
Q Fever. A random sub-sample of human sera was tested
using an indirect IgG Phase II ELISA (Coxiella burnetii ELISA IgG,
Vircell SL, Granada, Spain). Samples were classified as positive or
negative according to the manufacturer’s recommended cut-off
ranges and doubtful samples were re-tested. In order to assess the
suitability of the ELISA cut-off value for the Togo samples, the
immunofluorescent antibody test (IFA) for Phase II IgG was
performed by Vircell S.L. in Spain (Coxiella burnetii IFA IgG,
Vircell SL, Granada, Spain) [32].
Figure 1. Map of study site. The national borders of Togo are shown in red and the boundary of the Savannah Region is indicated by the dashed
red line. The red points correspond to the 25 randomly selected villages included in the survey.
doi:10.1371/journal.pone.0071501.g001
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A random sub-sample of sera from village livestock was tested
using an indirect IgG ELISA (CHEKIT Q-Fever Antibody Test
Kit, IDEXX Laboratories, ME, USA). Samples were classified as
positive or negative according to the manufacturer’s recommend-
ed cut-off ranges and doubtful samples were re-tested.
Hygroma Fluid Sampling and Culture
In March 2012, cattle with joint hygromas from study villages
and neighbouring villages were identified through discussion with
cattle owners or herders and local veterinary technicians. Fluid
samples from joint hygromas were collected from nine cattle, six of
which were from herds sampled within the village serosurvey. All
hygromas were involving the carpus, except for one over the hock.
After aseptic collection of joint fluid, a sterile swab tip was soaked
in the fluid and sealed in liquid Amies transport medium. Two
swabs were harvested per animal. The swabs were stored at 4uC
before transportation to Switzerland, according to international
biosafety standards, for microbiological culture at the Institute for
Veterinary Bacteriology, University of Bern.
The swabs were cultivated on tryptic soy agar plates supple-
mented with 5% sheep blood (BD, NJ, USA) and on Brucella-
selective agar (BSA). The BSA contained Brucella-medium base
(Oxoid, Basingstoke, UK), 5% inactivated horse serum and
7.5 mL modified Brucella Selective Supplement (Oxoid, Basing-
stoke, UK). The plates were incubated for 10 days at 37uC in 5%
CO2. Colonies from pure cultures were suspended in lysis buffer
(0.1 M Tris-HCl pH 8.5, 0.005% Tween 20, 0.24 mg/mL
Proteinase K) and incubated for 60 minutes at 60uC and for 15
minutes at 95uC. The lysates were then filter sterilised.
Identification of the genus Brucella was performed by realtime
PCR according to the protocol of Hinic et al [33]. Multiple Loci
Variable Number of Tandem Repeats Analysis (MLVA) was
carried out over 16 loci (panel 1, panel 2A and panel 2B markers)
for the isolated strains and for B. melitensis strain 16MT, as
previously described [34,35]. The PCR products were analysed
with the Agilent 2100 Bioanalyzer using a DNA 1000 LabChip kit
(Agilent Technologies, Waldbronn, Germany) according to the
manufacturer’s protocols, and compared with the results of De
Santis et al [10]. Some of the PCR products were sequenced in
order to confirm the exact size of the amplicons. The MLVA data
were analysed using the Brucella aggregated database hosted on
MLVAnet (http://mlva.u-psud.fr/) developed by University Paris
Sud in Orsay, France [36].
Data Analysis
Data were entered in duplicate into an Access 2003 database
(Microsoft, USA), in order to detect data entry errors, and
compared using the Data Compare function of Epi Info 3.5.3
(Centers for Disease Control and Prevention, USA). All statistical
analyses were performed in Stata 10.1 (StataCorp LP, USA).
As animals from the same village were observed to regularly mix
at common grazing and watering points, the clustering level for
livestock was considered to be the village rather than the
household. The apparent seroprevalence was calculated using
Generalised Estimating Equations (GEE) with a binomial distri-
bution and an independent correlation structure. To adjust for test
performance, a range of plausible values for sensitivity and
specificity were specified (presented in the Results section) from
which a value was randomly sampled for the calculation of an
adjusted seroprevalence. The model was run for 1,000 simulations,
with the random selection of sensitivity and specificity for each
simulation. The mean adjusted seroprevalence was then deter-
mined.
Mixed effects logistic regression was used to calculate odds ratios
to assess covariates such as demographic characteristics and
potential risk factors for exposure, as well as the relationship
between human and livestock seroprevalence at the village level.
To assess serological test performance for brucellosis, the level of
agreement between the ELISA and RBT was determined by
calculating the inter-rater agreement between two unique raters.
For human Q Fever, ELISA sensitivity and specificity were
calculated using IFA as the gold standard reference test [12].
Results
Human Serosurvey
From the 25 villages, 683 people participated in the survey, of
which 255 (37.3%) were of Fulani ethnicity. The age and sex
distribution are shown in Table 1. Consumption of non-boiled
dairy products was common, particularly amongst Fulani with
almost all adults (95.6%) reporting consumption compared to less
than two thirds (60.7%) of the rest of the population, hereafter
referred to as non-Fulani. Most households reported owning or
looking after cattle, sheep, or goats, with 96.9% Fulani and 83.4%
non-Fulani households reporting this livestock contact. Nearly
three quarters (73.9%) of Fulani men listed livestock as a principal
source of income, as opposed to 13.8% non-Fulani.
Brucella seroprevalence. Seroprevalence results for Brucella
spp. are presented in Table 2. Only five people were positive by
IgG ELISA and three people by RBT. One person was positive to
both tests. Of the three people positive by RBT, only one
remained positive after sequential serum dilution. This person was
also IgM ELISA positive. Overall, six of these 7 seropositive
people were of Fulani ethnicity. The apparent seroprevalence for
Fulani was 2.4% (95%CI: 1.0–5.6), compared to 0.2% (95%CI:
0.0–1.6) for the rest of the population, as shown in Table 2.
Seropositive participants were re-assessed by the study team for
symptoms compatible with active brucellosis. These participants
were not clinically unwell at the time of examination and none had
a clinical history supporting active disease, including the IgM
seropositive participant. They were provided with information
about the disease and were monitored by their local nurse.
C. burnetii seroprevalence. Two hundred and seventy-
eight human sera (134 Fulani and 144 non-Fulani), representing
40.7% of the total sample, were randomly selected for IFA and
ELISA. Serological evidence of exposure to Coxiella burnetii was
common, with 100 people having Phase II IgG titres by IFA
ranging from 1:32 to 1:256, in 23 of 25 villages. Assuming IFA to
be the gold standard for Q Fever diagnosis (i.e. 100% sensitivity
and specificity), the seroprevalence in non-Fulani was 26.9%
(95%CI: 20.4–30.6%) and 45.3% (37.6–53.3%) in Fulani using a
cut-off value of 1:32 as evidence of serological exposure [37]. The
odds of being seropositive was 2.3 times higher (95%CI: 1.4–3.8)
for Fulani compared to non-Fulani when adjusted for age and sex.
Only 7 people had titres of 1:256 which, as a single Phase II IgG
titre, could suggest recent or active infection [38]. However, none
of these cases reported symptoms during the previous month that
clinically supported such a diagnosis. Owning or looking after
livestock was associated with a greater odds of being seropositive
using an IFA cut-off value of 1:32, although the 95% confidence
intervals included 1. The odds ratios for seropositivity and contact
with cattle or small ruminants were 1.6 (95%CI: 0.9–2.9) and 1.3
(95%CI: 0.7–2.3), respectively. Consumption of non-boiled milk
did not increase the odds of seropositivity, with an odds ratio of 1.1
(95%CI: 0.5–2.3).
Using the manufacturer’s recommended ELISA cut-off value,
the sensitivity and specificity of the Phase II IgG ELISA were
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84.8% and 63.0%, respectively, for evidence of serological
exposure (IFA titre of 1:32). However, for IFA titres of 1:256,
which can be considered the threshold for recent or active
infection, sensitivity increased to 100% and specificity to 69.4%.
Animal Serosurvey
From the 25 villages, 596 cattle, 465 sheep, and 221 goats were
randomly sampled. Additionally, serum was collected at 11
different sites from 464 transhumant cattle of 18 herds originating
from Burkina Faso. Owners of transhumant cattle at two sites
refused to participate due to time constraints. The age and sex
distribution of animal subjects are shown in Table 1.
Brucella serology. Seroprevalence results for livestock are
presented in Table 2. Cattle seropositive to Brucella spp by indirect
IgG ELISA or RBT were only detected in half of the villages (13 of
25). The apparent seroprevalence by ELISA using the manufac-
turer’s recommended cut-off value was 9.4% (95%CI: 4.6–18.4%),
whereas the seroprevalence by RBT was lower at 5.7% (95%CI:
2.4–12.8%). Based on conservative estimates of indirect ELISA
sensitivity and specificity of 94–98% and 97–99% respectively
[26,39], the seroprevalence adjusted for ELISA performance was
8.9% (95%CI: 7.0–10.7%).
In transhumant cattle, the apparent seroprevalence was slightly
lower. The seroprevalence was 7.3% (95%CI: 3.5–14.7%) by
ELISA and 4.5% (95%CI: 2.4–8.5%) by RBT. The seropreva-
lence adjusted for ELISA performance was 6.2% (95%CI: 4.4–
8.2%). Overall, the two tests had an agreement of 95.9%.
The odds of being seropositive by ELISA increased with age.
When adjusted for age, cows had an odds of Brucella seropositivity
that was 5.3 times higher (95%CI: 1.5–18.7) than bulls. Results of
the univariate and age-adjusted analysis of predictors of brucellosis
seropositivity are shown in see Table 3. Seropositive cows had a
3.8 times greater odds (95%CI: 1.2–12.1) of having aborted a
foetus during the previous year than seronegative cows, when
adjusted for age.
All small ruminants were negative by indirect IgG ELISA.
Eleven were positive by RBT but were negative by CFT. Thus, the
apparent seroprevalence in sheep and goats was 0%.
C. burnetii serology. For testing by indirect IgG ELISA, 242
cattle, 207 sheep, and 198 goat sera were randomly selected. In
contrast to Brucella spp, C. burnetii seropositivity (meaning at least
one seropositive animal) was detected in almost all villages (24 of
25). In these 24 seropositive villages, the mean village-level
seroprevalence was 14.9% (range: 3.6–37.5%).
The apparent seroprevalence by ELISA using the manufactur-
er’s recommended cut-off value was 16.1% (95%CI: 8.8–21.5%)
in cattle, 16.2% (95%CI: 11.1–23.0%) in sheep, and 8.8%
(95%CI: 4.4–16.9%) in goats, using a GEE model with clustering
at the village level. Based on conservative estimates of ELISA
sensitivity and specificity of 90–94% and 97–99% respectively
[26,39], adjustment of seroprevalence for test performance
estimated seroprevalences to be 14.8% (95%CI: 10.8–19.2%) in
Table 1. Characteristics of study participants from 25 villages in northern Togo.
People
Ethnicity n Male Age in years
Median (range) #15
Fulani 255 118 (46.3%) 25.5 (5–85) 95 (37.3%)
Non-Fulani 428 242 (56.7%) 26 (5–90) 195 (45.6%)
Total 683 360 (52.7%) 26 (5–90) 290 (42.5%)
Animals
Species n Male Median age in years (range) –
Cattle: from villages 596 201 (33.7%) 6 (0.3–16) –
Cattle: transhumant* 464 93 (20.0%) 2 (0.5–15) –
Sheep 465 52 (11.2%) 3 (0.3–12) –
Goats 221 24 (10.9%) 2 (0.3–12) –
*Transhumant cattle were sampled from 18 herds across 11 sites.
doi:10.1371/journal.pone.0071501.t001
Table 2. Seroprevalence of brucellosis (Brucella spp) and Q
Fever (Coxiella burnetii) in people and livestock.
Brucellosis
Population n Seroprevalence (%) (95%CI)
Unadjusted
Adjusted for ELISA
performance
Humans: Fulani 255 2.4 (1.0–5.6) –
Humans: non-Fulani 428 0.2 (0.0–1.6) –
Cattle: from villages 596 9.2 (4.3–18.6) 8.9 (7.0–10.7)
Cattle: transhumant 464 7.3 (3.5–14.7) 7.1 (5.0–9.5)
Sheep 465 0 –
Goats 221 0 –
Q Fever
Humans: Fulani 134 45.5 (37.7–53.6)* –
Humans: non-Fulani 144 27.1 (20.6–34.7)* –
Cattle: from villages 242 15.7 (11.6–20.9) 14.5 (10.3–19.0)
Sheep 207 16.4 (11.4–23.1) 15.0 (11.1–20.3)
Goats 198 7.1 (3.3–14.6) 6.6 (3.5–9.6)
*Using IFA cut-off of 1:32 for serological evidence of exposure.
doi:10.1371/journal.pone.0071501.t002
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cattle, 14.4% (95%CI: 10.6–19.1%) in sheep, and 8.3% (95%CI:
4.2–12.4%) in goats.
Cows that had aborted a foetus during the previous year had an
odds of being C. burnetii seropositive that was 6.7 times higher
(95%CI: 1.3–34.8) than those that had not aborted (Table 3),
when adjusted for age. This relationship was not evident for small
ruminants. Sex and age were not predictors of seropositivity.
There was only a very weak linear correlation between the village-
level seroprevalence of people and livestock, with an adjusted R-
squared value of 0.05.
Hygroma Fluid Culture
Although there was no growth on the BSA plates, mixed
bacterial cultures grew on blood agar. Brucella-like colonies were
then purified onto blood agar plates and isolates were recovered
from hygroma samples from three cows, all of which were
seropositive by RBT and ELISA. The genus Brucella was
confirmed by realtime PCR. Assessment by MLVA-8 (panel 1)
identified the isolates as B. abortus. Each isolate had a distinct
Variable Number of Tandem Repeats (VNTR) profile by MLVA-
16 (panels 1, 2A and 2B). The full biotyping results will be
presented in detail in a separate publication.
Discussion
This is the first study of brucellosis and Q Fever in linked animal
and human populations in Togo. Simultaneous assessment of the
exposure of people and animals provides a more complete
epidemiological picture and deepens our understanding of
infection patterns at the animal-human interface. The findings of
this study are relevant not only for Togo, but also for neighbouring
countries in West Africa, given the frequent cross-border
movement of livestock often occurring outside official channels.
Most published high quality data on the incidence of human
brucellosis in Africa comes from northern Africa [6], where B.
melitensis has an important impact on human and animal health
[40]. The findings of this study suggest a different disease
epidemiology in northern Togo, with no evidence of circulation
of B. melitensis. Despite the ownership/management of livestock
and consumption of non-boiled dairy products being common,
brucellosis does not appear to pose a major human health problem
in the study zone. The disease may, however, still have a
significant economic impact through a reduction in cattle
productivity. The distinct VNTR profiles of the three B. abortus
isolates obtained from the culture of bovine hygroma fluid suggests
that the organism has been circulating in the study zone for some
time. Cows that were seropositive for Brucella spp. or C. burnetii
were more likely to have aborted a foetus during the previous year.
Indeed, the Food and Agricultural Organization of the United
Nations (FAO) estimated in 2002 that milk and meat production in
West Africa could increase by US$56–168 million/year if
brucellosis were eliminated [41].
Due to the absence of a perfect test, Brucella serology is
notoriously difficult to interpret. All serological tests have
limitations when used as screening tools [42]. In this study, the
apparent seroprevalence has been adjusted for the performance of
the serological tests and the influence of age and sex. However, it
remains only an approximation of the true disease seroprevalence
in the population. Exposed but seronegative animals, for example,
are not captured in the adjusted seroprevalence estimates. The
OIE guidelines for brucellosis state that both the RBT and ELISA
are suitable screening tests for the control of brucellosis at the local
or national level. Positive reactions should be tested by a
confirmatory strategy, such as the CFT [31,42]. Given that the
11 small ruminants in this study that were seropositive by RBT
and seronegative by ELISA remained negative when tested by
CFT, the ELISA may be a more specific test than the RBT for
brucellosis. It may also have a higher sensitivity, with more cattle
diagnosed seropositive by ELISA than by RBT. However, an
additional confirmatory test would be required in order to
investigate this further. The levels of seropositivity of village and
transhumant cattle were similar. Given the frequent cross-border
movements and mixing of livestock in West Africa, these findings
suggest that the livestock disease status in one country may be
potentially linked to that of its neighbour.
Exposure of animals and people to C. burnetii was common,
although the proportion of seroconversions representing clinical
disease is not known. More research is needed into identifying
appropriate cut-off values for diagnostic tests in endemic settings.
However, given that 5.0% of 870 acute febrile patients presenting
to health centres in Tanzania were diagnosed with acute Q Fever
Table 3. Predictors of seropositivity to Brucella spp and Coxiella burnetii by ELISA in cattle.
Bovine Brucellosis (Brucella spp)
Predictor
Number of subjects
(proportion seropositive) Odds ratio (95%CI)
Univariate Analysis Adjusted for sex Adjusted for age
11 yrs–16 yrs*u 48 (18.0%) 22.9 (7.2–73.3) 16.2 (4.9–53.4) –
6 yrs–10 yrs*u 378 (12.2%) 5.7 (2.9–11.3) 4.4 (2.2–8.8) –
3 mths–5 yrs* 613 (20.8%) – – –
Cows 766 (11.2%) 9.8 (2.9–32.9) – 5.3 (1.5–18.7)
Bulls 294 (1.0%) – – –
Abortion during previous year+ 32 (31.3%) 4.1 (1.4–12.3) – 3.8 (1.2–12.1)
Bovine Q Fever (Coxiella burnetii)
Abortion during previous year+ 8 (16.0%) 6.3 (1.2–33.2) – 6.7 (1.3–34.8)
*Excluding animals for whom age was not known (n = 21).
uThe reference category for the odds ratios is 3 mths –5 yrs.
+Excluding cows under 3 years of age.
doi:10.1371/journal.pone.0071501.t003
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[43], it is indeed likely that the pathogen causes substantial
morbidity in Togo.
Cultural practices may influence zoonotic disease risk. The
seroprevalence of both diseases were higher amongst the Fulani
compared to the rest of the population, possibly reflecting their
greater ownership or management of livestock and their increased
consumption of non-boiled dairy products. However, a positive
association between the consumption of raw milk and seroposi-
tivity to C. burnetii could not be demonstrated in this study. The
role of milk consumption in C. burnetii transmission is not fully
understood, with asymptomatic seroconversion without clinical
illness reported [44,45].
General Recommendations
This is the first joint human and animal zoonotic disease study
in Togo, which is an important component of the broader One
Health concept. A One Health approach to zoonotic diseases
research should be encouraged in Togo, as it may guide disease
prevention and control strategies, bring economic benefits to both
sectors and strengthen the health system as a whole [15].
Community awareness of practices risking exposure to zoonotic
diseases is needed. Given their higher levels of exposure, this is
particularly important for Fulani communities. Boiling milk before
consumption would reduce the risk of exposure to foodborne
pathogens in general. The importance of avoiding contact with
aborted materials, as well as basic hygiene practices including
handwashing and environmental cleanliness [46], should also be
communicated. Given the low levels of literacy amongst study
participants, appropriate methods include verbal communication
of health messages by the local nurse or the village and Fulani
chiefs, or the use of visual tools. In order to successfully engage
communities, the support of both the village chief and the Fulani
chief is essential. However, information, education and commu-
nication campaigns are costly to implement. These costs would
need to be assessed in relation to the expected combined benefits
for human health and livestock productivity [18].
Diagnosing and treating zoonotic diseases is particularly
challenging in malaria-endemic countries [47,48]. The screening
of fever cases for differential diagnoses, including Q Fever, should
be carried out in order to determine their role in febrile illness
[14,43]. This would first require training of health workers and
laboratory staff, and strengthening of laboratory capacity. In terms
of animal health, the higher odds of abortion by seropositive cows
suggests that livestock productivity is affected by both brucellosis
and Q Fever. Further investigation into the economic impact of
these diseases would allow the identification and tailoring of cost-
effective control strategies, such as vaccination. These strategies
must be assessed in the context of overall benefits to public health,
the livestock production sector, and household economies [5].
There may be opportunities to combine the selected interventions
with other livestock health programs, such as the anthrax
vaccination campaigns which take place annually in the study
zone.
Study Limitations
There are several limitations to this study. Firstly, the
proportion of the total population sampled in each location is
unknown, due to the unavailability of recent, comprehensive
census data. The age distributions of the human and animal study
populations are unlikely to reflect the true age distribution of the
general population. Secondly, the village survey was conducted
during the transition period between the dry and wet seasons
(May-June 2011), before road access became too difficult due to
flooding. In some particularly dry areas, livestock left the village
early in the morning in search of watering points and grazing
pasture. These animals were not captured by the sampling strategy
of the field team. Given the practicalities of conducting a field
survey in remote, rural communities, this potential source of
selection bias was unfortunately unavoidable. There may have also
been temporal variations in pathogen exposure and clinical
symptoms that were not captured by the cross-sectional study
design. Finally, more detailed information about risk factors,
including the dairy products consumed and the level of contact
with livestock and abortion materials, would have allowed a more
thorough assessment of exposure risk.
Conclusions
This is the first epidemiological study of brucellosis and Q Fever
in linked human and animal populations in Togo, providing much
needed data for the West African region. Brucella spp and C. burnetii
are shown to be circulating in the study zone, but further research
is needed into their clinical and economic impact. Education of the
community about practices risking exposure to zoonotic diseases is
needed.
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